Galectin Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Galectin therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Galectin Therapeutic Today - Breaking & Trending Today

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

29.03.2024 - NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) - Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended . ....

Richard Uihlein , Chris Calabrese , Jack Callicutt , Khurram Jamil , Kevin Gardner , Benjamins Carson , Pol Boudes , Company Annual Report On Form , Belapectin Program , Drug Administration , Company Contact , Exchange Commission , Galectin Therapeutics Inc , Chief Medical Officer , Fast Track Designation , Data Safety , Monitoring Board , Liver Meeting , American Association , Liver Diseases , Annual Report , Fast Track , Private Securities Litigation Reform Act , Chief Financial , Relations Contacts , Galectin Therapeutics ,

Galectin Therapeutics : Reports 2023 Financial Results and Provides Business Update - Form 8-K -March 29, 2024 at 07:59 am EDT

Galectin Therapeutics, Inc. , the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31,. ....

Khurram Jamil , Chris Calabrese , Benjamins Carson , Jack Callicutt , Joel Lewis , Pol Boudes , Richard Uihlein , Kevin Gardner , Company Annual Report On Form , Exchange Commission , Company Contact , Belapectin Program , Drug Administration , Galectin Therapeutics Inc , Galectin Therapeutics Reports , Provides Business Update , Chief Executive Officer , Galectin Therapeutics , Metabolic Dysfunction Associated Steatohepatitis , Safety Monitoring Board , Chief Medical Officer , Fast Track Designation , Program Highlights , Data Safety , Monitoring Board , Liver Meeting ,

Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development

NORCROSS, Ga., March 12, 2024 (GLOBE NEWSWIRE) Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target . ....

United States , Polf Boudes , Chris Calabrese , Khurram Jamil , Jack Callicutt , Kevin Gardner , Company Annual Report On Form , Galectin Therapeutics Inc , King Edward Medical University At Lahore , Organon Pharmaceuticals United States , Clinical Development , Mallinckrodt Pharmaceuticals , Ikaria Inc , Seaton Hall University , Company Contact , Drug Administration , Vice President , Chief Medical , New Drug Registration , Vice President Hepatology , New England Journal , General Surgery , King Edward Medical University , Fast Track , Private Securities Litigation Reform Act , Annual Report ,

Retail investors account for 55% of Galectin Therapeutics Inc.'s (NASDAQ:GALT) ownership, while insiders account for 21%

Key Insights Galectin Therapeutics' significant retail investors ownership suggests that the key decisions are. ....

Joel Lewis , Richard Uihlein , Galectin Therapeutics Inc , Galectin Therapeutic , Galectin Therapeutics , Galectin Therapeutics Inc , Retail Investors ,

Reviewing Xilio Therapeutics (NASDAQ:XLO) & Galectin Therapeutics (NASDAQ:GALT)

Reviewing Xilio Therapeutics (NASDAQ:XLO) & Galectin Therapeutics (NASDAQ:GALT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Xilio Therapeutics Inc , Galectin Sciences , Sciences Inc , Pharmaceuticals Inc , Galectin Therapeutics Inc , Xilio Therapeutics , Get Free Report , Galectin Therapeutics , Given Xilio Therapeutic , Galectin Therapeutic , Therapeutics Inc , Xilio Therapeutics Daily ,